Immuneering Announces Participation in February Investor Conferences
February 01, 2024 08:00 ET
|
Immuneering Corporation
CAMBRIDGE, Mass., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company seeking to develop universal-RAS/RAF medicines for broad populations of...
Icosavax to Participate in the Guggenheim Healthcare Talks 5th Annual Inflammation, Neurology & Immunology (INI) Conference
October 31, 2023 08:00 ET
|
Icosavax, Inc.
SEATTLE, Oct. 31, 2023 (GLOBE NEWSWIRE) -- Icosavax, Inc. (Nasdaq: ICVX), a biopharmaceutical company leveraging its innovative virus-like particle (VLP) platform technology to develop vaccines...
Onconova Therapeutics to Present at the 2023 Guggenheim Oncology Conference
February 01, 2023 08:00 ET
|
Onconova Therapeutics, Inc.
NEWTOWN, Pa., Feb. 01, 2023 (GLOBE NEWSWIRE) -- Onconova Therapeutics, Inc. (NASDAQ: ONTX), (“Onconova”), a clinical-stage biopharmaceutical company focused on discovering and developing novel...
Praxis Precision Medicines to Present at Guggenheim Nantucket Therapeutics Conference
September 21, 2022 09:00 ET
|
Praxis Precision Medicines, Inc.
BOSTON, Sept. 21, 2022 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies...
Vir Biotechnology to Participate in the Guggenheim 2nd Annual Vaccine & Infectious Disease Day Conference
September 30, 2021 16:05 ET
|
Vir Biotechnology, Inc.
SAN FRANCISCO, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced that Phil Pang, M.D., Ph.D., chief medical officer, is scheduled to present at the Guggenheim...
Youth INC Celebrates 25 Years of Impact Raising Over $3M for New York City Kids
November 14, 2019 14:30 ET
|
Youth INC
NEW YORK, Nov. 14, 2019 (GLOBE NEWSWIRE) -- Youth INC held its 25th Annual Celebration Gala at the Grand Hyatt New York last night. The event raised over $2.1 million to directly support Youth INC’s...
BeiGene to Present at the Guggenheim Healthcare Talks Idea Forum – Oncology Day
February 07, 2019 07:00 ET
|
BeiGene, LTD.
CAMBRIDGE, Mass., and BEIJING, China, Feb. 07, 2019 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage biopharmaceutical company focused on developing and...